EA201201416A1 - Соединение для лечения состояния или заболевания органов дыхания - Google Patents
Соединение для лечения состояния или заболевания органов дыханияInfo
- Publication number
- EA201201416A1 EA201201416A1 EA201201416A EA201201416A EA201201416A1 EA 201201416 A1 EA201201416 A1 EA 201201416A1 EA 201201416 A EA201201416 A EA 201201416A EA 201201416 A EA201201416 A EA 201201416A EA 201201416 A1 EA201201416 A1 EA 201201416A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- disease
- condition
- connection
- respiratory system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Настоящее изобретение относится к лечению, облегчению, предупреждению или уменьшению симптомов обострения астмы или хронического обструктивного заболевания легких (COPD), типичным клиническим проявлением которых обычно служит сниженная функция легких.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2010901601A AU2010901601A0 (en) | 2010-04-15 | Compound for the treatment of respiratory condition or disease | |
PCT/AU2011/000434 WO2011127538A1 (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201201416A1 true EA201201416A1 (ru) | 2013-03-29 |
EA025224B1 EA025224B1 (ru) | 2016-12-30 |
Family
ID=44788654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201201416A EA025224B1 (ru) | 2010-04-15 | 2011-04-14 | ПРИМЕНЕНИЕ 3-ЭТОКСИ-6-{2-[1-(6-МЕТИЛПИРИДАЗИН-3-ИЛ)ПИПЕРИДИН-4-ИЛ]ЭТОКСИ}БЕНЗО[d]ИЗОКСАЗОЛА ИЛИ ЕГО ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМОЙ СОЛИ ПРИ ЛЕЧЕНИИ ИЛИ ОБЛЕГЧЕНИИ СИМПТОМОВ АСТМЫ |
Country Status (16)
Country | Link |
---|---|
US (1) | US20110257192A1 (ru) |
EP (1) | EP2558097B1 (ru) |
JP (1) | JP6148618B2 (ru) |
KR (1) | KR20130106267A (ru) |
CN (2) | CN105560245A (ru) |
AU (1) | AU2011241478B2 (ru) |
BR (1) | BR112012026244A2 (ru) |
CA (1) | CA2796207A1 (ru) |
EA (1) | EA025224B1 (ru) |
ES (1) | ES2647223T3 (ru) |
IL (1) | IL222244A0 (ru) |
MX (1) | MX2012011938A (ru) |
NZ (1) | NZ603040A (ru) |
SG (2) | SG10201502391WA (ru) |
WO (1) | WO2011127538A1 (ru) |
ZA (1) | ZA201207696B (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110128406B (zh) | 2013-04-12 | 2021-08-27 | 制药有限责任公司 | 戊二酰亚胺衍生物、其用途、基于所述衍生物的药物组合物及戊二酰亚胺衍生物的制备方法 |
MX2016017282A (es) * | 2014-06-20 | 2017-07-13 | Aviragen Therapeutics Inc | Forma de base libre cristalina anhidra de 6-{2-[1-(6-metil-3-pirid azinil)-4-piperidinil]etoxi}-3-etoxi-1,2-bencisoxazol. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPR213700A0 (en) * | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
US20060167109A1 (en) * | 2002-02-14 | 2006-07-27 | Pevear Daniel C | Methods of reducing rhinovirus contagion and related compositions |
DE602004014728D1 (de) * | 2003-02-21 | 2008-08-14 | Apodemus Ab | Behandlung von durch das ljungan-virus ausgelösten erkrankungen durch verwendung von pleconaril |
US9308199B2 (en) * | 2004-04-29 | 2016-04-12 | Honeywell International Inc. | Medicament formulations |
WO2006029182A2 (en) * | 2004-09-07 | 2006-03-16 | The La Jolla Institute For Molecular Medicine | Use of mdl-100,907 for treatment of allergic and eosinophil mediated diseases |
AR057623A1 (es) * | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
WO2009143571A1 (en) * | 2008-05-27 | 2009-12-03 | Biota Scientific Management Pty Ltd | Antiviral salts |
TW201016215A (en) * | 2008-07-17 | 2010-05-01 | Schering Corp | Compositions and uses of antiviral active pharmaceutical agents |
-
2011
- 2011-04-14 NZ NZ60304011A patent/NZ603040A/en not_active IP Right Cessation
- 2011-04-14 MX MX2012011938A patent/MX2012011938A/es not_active Application Discontinuation
- 2011-04-14 SG SG10201502391WA patent/SG10201502391WA/en unknown
- 2011-04-14 BR BR112012026244A patent/BR112012026244A2/pt not_active IP Right Cessation
- 2011-04-14 AU AU2011241478A patent/AU2011241478B2/en not_active Ceased
- 2011-04-14 ES ES11768285.6T patent/ES2647223T3/es active Active
- 2011-04-14 WO PCT/AU2011/000434 patent/WO2011127538A1/en active Application Filing
- 2011-04-14 CN CN201510982692.9A patent/CN105560245A/zh active Pending
- 2011-04-14 SG SG2012073565A patent/SG184430A1/en unknown
- 2011-04-14 CN CN2011800192025A patent/CN102844032A/zh active Pending
- 2011-04-14 EP EP11768285.6A patent/EP2558097B1/en not_active Not-in-force
- 2011-04-14 JP JP2013504064A patent/JP6148618B2/ja active Active
- 2011-04-14 EA EA201201416A patent/EA025224B1/ru not_active IP Right Cessation
- 2011-04-14 CA CA2796207A patent/CA2796207A1/en not_active Abandoned
- 2011-04-14 KR KR1020127029232A patent/KR20130106267A/ko not_active Application Discontinuation
- 2011-04-15 US US13/087,624 patent/US20110257192A1/en not_active Abandoned
-
2012
- 2012-10-09 IL IL222244A patent/IL222244A0/en unknown
- 2012-10-12 ZA ZA2012/07696A patent/ZA201207696B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2011241478B2 (en) | 2016-12-01 |
EP2558097A1 (en) | 2013-02-20 |
KR20130106267A (ko) | 2013-09-27 |
IL222244A0 (en) | 2012-12-31 |
ES2647223T3 (es) | 2017-12-20 |
MX2012011938A (es) | 2013-01-28 |
EP2558097B1 (en) | 2017-10-25 |
JP2013523844A (ja) | 2013-06-17 |
JP6148618B2 (ja) | 2017-06-14 |
WO2011127538A1 (en) | 2011-10-20 |
EP2558097A4 (en) | 2013-09-11 |
NZ603040A (en) | 2015-03-27 |
CA2796207A1 (en) | 2011-10-20 |
ZA201207696B (en) | 2014-03-26 |
BR112012026244A2 (pt) | 2016-07-12 |
CN102844032A (zh) | 2012-12-26 |
AU2011241478A1 (en) | 2012-11-01 |
SG184430A1 (en) | 2012-11-29 |
US20110257192A1 (en) | 2011-10-20 |
SG10201502391WA (en) | 2015-05-28 |
CN105560245A (zh) | 2016-05-11 |
EA025224B1 (ru) | 2016-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201190108A1 (ru) | Фармацевтическая композиция для ингаляции | |
WO2012110770A3 (en) | Combination of glycopyrrolate and a beta2 -agonist | |
EA201200876A1 (ru) | Новые антагонисты рецептора ccr2 и их применение | |
EA201400591A1 (ru) | Ингалятор | |
WO2012103216A3 (en) | Apparatus and methods for assisting breathing | |
GEP20186885B (en) | Novel compounds | |
CL2014000122A1 (es) | Compuestos derivados de indazol, inhibidores de janus quinasa (jak); composicion farmaceutica que los comprende; y su uso para tratar rinitis alergica, congestion nasal, asma, bronquitis cronica, artritis, insuficiencia cardiaca, colitis ulcerativa, infeccion viral y bacteriana, cancer y alzheimer, entre otras enfermedades. | |
MX2011008799A (es) | Polipeptidos, dominios variables de anticuerpos, y antagonistas anti-tnfr1 mejorados. | |
CL2008001593A1 (es) | Compuestos derivados de heterociclos, antagonistas para el ccr2; y uso de los compuestos para tratar afecciones o enfermedades del tracto respiratorio, como enfermedad pulmonar obstructiva cronica y asma. | |
EA201591269A1 (ru) | Способы лечения аутоиммунных, респираторных и воспалительных расстройств ингаляцией n-оксида рофлумиласта | |
UY31686A1 (es) | Nueva dosificacion y formulacion | |
WO2015018840A3 (en) | Novel means to decrease the negative effects of smoking | |
UY31687A1 (es) | Nueva dosificacion y formulacion | |
MY174877A (en) | Anti-adrenomedullin (adm) antibpdy or anti-adm antibody fragment of anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic of acute disease or acute condition | |
GB2496800A (en) | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition | |
WO2011021203A3 (en) | Desferrioxamine-metal complexes for the treatment of immune-related disorders | |
EA201290374A1 (ru) | Аэрозольная композиция для copd | |
TR201000733A2 (tr) | Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler. | |
EA201201395A1 (ru) | Кнопочное устройство мундштука ингалятора сухого порошка | |
WO2013095091A3 (en) | Rsv g protein specific antibodies | |
EP2585067A4 (en) | COMPOUND FOR THE TREATMENT OF ENTEROVIRUS | |
WO2015023508A3 (en) | Methods for improving asthma symptoms using benralizumab | |
MX2019013468A (es) | Metodos para tratar la enfermedad pulmonar obstructiva cronica usando benralizumab. | |
EA201201416A1 (ru) | Соединение для лечения состояния или заболевания органов дыхания | |
TR201905319T4 (tr) | Nevralji, ağrı, KOAH (Kronik, Obstruktif Akciğer Hastalığı) ve astım tedavisinde TRPM8-inhibitörleri olarak yararlı 2-aril-4-hidroksi-1,3-tiyazol türevleri. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |